- Home
- JXG vs NUWE Comparison
JXG vs NUWE Comparison
Compare JXG & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JXG
- NUWE
- Stock Information
- Founded
- JXG N/A
- NUWE 1999
- Country
- JXG China
- NUWE United States
- Employees
- JXG N/A
- NUWE N/A
- Industry
- JXG
- NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- JXG
- NUWE Health Care
- Exchange
- JXG Nasdaq
- NUWE Nasdaq
- Market Cap
- JXG 4.7M
- NUWE 3.9M
- IPO Year
- JXG N/A
- NUWE N/A
- Fundamental
- Price
- JXG $0.94
- NUWE $4.80
- Analyst Decision
- JXG
- NUWE
- Analyst Count
- JXG 0
- NUWE 0
- Target Price
- JXG N/A
- NUWE N/A
- AVG Volume (30 Days)
- JXG 118.3K
- NUWE 150.5K
- Earning Date
- JXG 05-15-2025
- NUWE 08-14-2025
- Dividend Yield
- JXG N/A
- NUWE N/A
- EPS Growth
- JXG N/A
- NUWE N/A
- EPS
- JXG 0.86
- NUWE N/A
- Revenue
- JXG $49,840,288.00
- NUWE $8,318,000.00
- Revenue This Year
- JXG N/A
- NUWE $6.53
- Revenue Next Year
- JXG N/A
- NUWE $51.63
- P/E Ratio
- JXG $1.06
- NUWE N/A
- Revenue Growth
- JXG 56.53
- NUWE N/A
- 52 Week Low
- JXG $0.55
- NUWE $4.67
- 52 Week High
- JXG $8.40
- NUWE $175.98
- Technical
- Relative Strength Index (RSI)
- JXG 37.93
- NUWE 31.17
- Support Level
- JXG $0.85
- NUWE $5.00
- Resistance Level
- JXG $1.04
- NUWE $5.07
- Average True Range (ATR)
- JXG 0.08
- NUWE 0.26
- MACD
- JXG 0.01
- NUWE 0.23
- Stochastic Oscillator
- JXG 39.33
- NUWE 8.71
About JXG JX Luxventure Limited Common Stock
JX Luxventure Group Inc is engaged in the tourism sector and supplying related products, including technology solutions, to business partners in China, both online and offline. The company operates in three segments Tourism products, Technology, and Cross board merchandise The majority of the group revenue is generated from Tourism products.
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.